Files
2026-07-06 17:27:20 -04:00

4.5 KiB
Raw Permalink Blame History

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
type title description jurisdiction legislature session identifier citation classification subjects status primary_sponsors version_count action_count vote_count first_action last_action source source_identifier source_url source_hash vintage source_snapshot retrieved_at confidence tags
Bill Health Insurance - Prescription Insulin Drugs - Limits on Copayment and Coinsurance (Insulin Cost Reduction Act) Health Insurance - Prescription Insulin Drugs - Limits on Copayment and Coinsurance (Insulin Cost Reduction Act) us/states/md Maryland General Assembly 2022 HB 1397 Maryland HB 1397 (2022)
bill
enacted
B. Barnes
Bagnall
Bhandari
Carey
Carr
Charles
Chisholm
Cullison
Henson
Hill
Howell
Johnson
K. Young
Kaiser
Kelly
Kerr
Kipke
Landis
Lehman
Morgan
Pena-Melnyk
Pendergrass
R. Lewis
Reilly
Reznik
Rosenberg
Saab
Sample-Hughes
Szeliga
Valderrama
Valentino-Smith
3 14 2 2022-02-17 2022-05-16 openstates ocd-bill/51ee8ac3-c05f-4647-bff5-425b339347a8 http://mgaleg.maryland.gov/mgawebsite/Legislation/Details/hb1397?ys=2022RS&search=True 5aff2044a224fb8c761518816584dd75c42d73d430ee53cff94b2e2081afb82f 2026-07-01 https://data.openstates.org/daily/2026-07-01/public.pgdump 2026-07-06 reported
legislation
bill
us-md

Maryland HB 1397 (2022) — Health Insurance - Prescription Insulin Drugs - Limits on Copayment and Coinsurance (Insulin Cost Reduction Act)

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

  1. Chapter - Health Insurance - Prescription Insulin Drugs - Limits on Copayment and Coinsurance (Insulin Cost Reduction Act) (committee substitute) — source
  2. First - Health Insurance - Prescription Insulin Drugs - Limits on Copayment and Coinsurance (Insulin Cost Reduction Act) (committee substitute) — source
  3. Third - Health Insurance - Prescription Insulin Drugs - Limits on Copayment and Coinsurance (Insulin Cost Reduction Act) (committee substitute) — source

Votes

  • On Third Reading — 1300 (pass) · lower
  • On Third Reading — 450 (pass) · upper

Sponsors

  • B. Barnes — primary (person)
  • Bagnall — primary (person)
  • Bhandari — primary (person)
  • Carey — primary (person)
  • Carr — primary (person)
  • Charles — primary (person)
  • Chisholm — primary (person)
  • Cullison — primary (person)
  • Henson — primary (person)
  • Hill — primary (person)
  • Howell — primary (person)
  • Johnson — primary (person)
  • K. Young — primary (person)
  • Kaiser — primary (person)
  • Kelly — primary (person)
  • Kerr — primary (person)
  • Kipke — primary (person)
  • Landis — primary (person)
  • Lehman — primary (person)
  • Morgan — primary (person)
  • Pena-Melnyk — primary (person)
  • Pendergrass — primary (person)
  • R. Lewis — primary (person)
  • Reilly — primary (person)
  • Reznik — primary (person)
  • Rosenberg — primary (person)
  • Saab — primary (person)
  • Sample-Hughes — primary (person)
  • Szeliga — primary (person)
  • Valderrama — primary (person)
  • Valentino-Smith — primary (person)

Timeline

The legislative action history — every referral, reading, and vote.

  • 2022-02-17 First Reading House Rules and Executive Nominations referral-committee
  • 2022-03-03 Rereferred to Health and Government Operations
  • 2022-03-03 Hearing 3/15 at 1:30 p.m.
  • 2022-03-18 Favorable with Amendments Report by Health and Government Operations committee-passage-favorable
  • 2022-03-18 Favorable with Amendments { committee-passage-favorable
  • 2022-03-18 Second Reading Passed with Amendments
  • 2022-03-21 Third Reading Passed passage
  • 2022-03-21 Referred Finance referral-committee
  • 2022-04-04 Favorable Report by Finance committee-passage-favorable
  • 2022-04-05 Favorable Adopted committee-passage-favorable
  • 2022-04-05 Second Reading Passed
  • 2022-04-06 Third Reading Passed passage
  • 2022-04-07 Returned Passed
  • 2022-05-16 Approved by the Governor - Chapter 405 executive-signature

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/51ee8ac3-c05f-4647-bff5-425b339347a8. Confidence: reported (aggregated from official Maryland legislature records).